Inhibition of lymphatic metastasis in neuroblastoma by a novel neutralizing antibody to vascular endothelial growth factor-D
Version of Record online: 30 OCT 2012
© 2012 Japanese Cancer Association
Volume 103, Issue 12, pages 2144–2152, December 2012
How to Cite
(Cancer Sci 2012; 103: 2144–2152)
- Issue online: 5 DEC 2012
- Version of Record online: 30 OCT 2012
- Accepted manuscript online: 1 SEP 2012 02:24AM EST
- Manuscript Accepted: 24 AUG 2012
- Manuscript Revised: 20 AUG 2012
- Manuscript Received: 23 MAY 2012
Fig. S1. Evaluation of the specificity of vascular endothelial growth factor (VEGF)-D immunohistochemical analysis.
Fig. S2. Comparison of profile between SK-N-DZ and SK-N-DZ-luc cells.
Fig. S3. Expression of VEGFR-2 and VEGFR-3 in SK-N-DZ-luc cells.
Fig. S4. Plot of photons and SK-N-DZ-luc number in each mouse shown in Figure 5(c).
Fig. S5. Immunohistochemical analysis of mCD31 in SK-N-DZ-luc xenograft.
Fig. S6. Expression of vascular endothelial growth factor.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.